Large cardiovascular outcome trials, including LEADER (liraglutide), SUSTAIN-6 (semaglutide), and REWIND (dulaglutide), have provided valuable insights into lipid changes
Its important for patients and their caregivers to monitor for any significant changes in mood, which might include: Feelings of sadness or hopelessness Loss of interest in activities once enjoyed Changes in sleep patterns 8
Patient preference or comfort: Some patients feel a slightly longer needle improves confidence that the medication is being delivered into the correct layer, especially if theyve had inconsistent results or site-specific issues (e.g leakage or irritation)
Biermann has heard from many GLP-1 users who want to stop the medication and is studying whether gradually spacing out doses such as moving from weekly injections to every other week can help maintain weight loss and other health benefits
No GLP-1 injections use a very small needle and are designed for easy, at-home use